Vraylar 1.5 MG capsule 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FZ98W
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,736
Award facts
- Contract value 100% obligated
- $17,736.37 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on December 15, 2025, for the supply of Vraylar 1.5 mg capsules (30-count units) with a ceiling value of $17,736.37. This competitively awarded, non-set-aside contract represents a firm fixed price delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award is set for ultimate completion by December 16, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Vraylar is a branded antipsychotic medication used in the treatment of schizophrenia and bipolar disorder, supporting the federal government's pharmaceutical supply chain for military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen's comprehensive $999,999,999.00 Pharmaceutical Prime Vendor Global Program IDC with DLA Troop Support Medical, which extends through December 2026. The parent contract enables the company to supply a broad portfolio of pharmaceutical products and medical commodities to support military healthcare operations worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania, maintains an extensive track record of competitively awarded federal contracts across multiple therapeutic domains, demonstrating its capability to meet the Defense Logistics Agency's critical medical procurement requirements.
Quick answers
Who was awarded contract SPE2DR26FZ98W?
SPE2DR26FZ98W was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 15, 2025.
How much is contract SPE2DR26FZ98W worth?
The government has obligated $17,736 on SPE2DR26FZ98W.
Is contract SPE2DR26FZ98W an order under another contract?
Yes. SPE2DR26FZ98W is a delivery order under SPE2DR25D2014, an indefinite delivery contract.
Was contract SPE2DR26FZ98W competed?
The extent of competition for SPE2DR26FZ98W was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award